PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

ledipasvir/sofosbuvir vs rosuvastatin

Side-by-side comparison of ledipasvir/sofosbuvir and rosuvastatin. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

moderate Known Drug Interaction

Intervention: Sofosbuvir/velpatasvir/voxilaprevir Ledipasvir/sofosbuvir Avoid concomitant use with rosuvastatin.

Recommendation: You should avoid using these two medications at the same time.

Drug Class
ledipasvir/sofosbuvir NS5A/NS5B Inhibitor (HCV)
rosuvastatin HMG-CoA Reductase Inhibitor (Statin)
Type
ledipasvir/sofosbuvir Prescription
rosuvastatin Prescription
Summary
ledipasvir/sofosbuvir

Harvoni is a medicine that contains ledipasvir and sofosbuvir. It is used to treat chronic hepatitis C virus (HCV) infection in adults and children 3 years and older.

rosuvastatin

Rosuvastatin is a drug that lowers cholesterol. It helps to reduce the risk of heart problems and stroke.

What It Treats
ledipasvir/sofosbuvir

Harvoni treats chronic Hepatitis C virus (HCV) genotypes 1, 4, 5, or 6. It can be used if you don't have cirrhosis or if you have compensated cirrhosis. If you have genotype 1 with decompensated cirrhosis or are a liver transplant recipient with genotype 1 or 4, you will take Harvoni with another medicine called ribavirin.

rosuvastatin

Rosuvastatin is used to lower bad cholesterol (LDL) in adults and children. It can also slow down the hardening of arteries in adults. This medicine also treats high triglycerides and certain inherited cholesterol disorders.

How It Works
ledipasvir/sofosbuvir

Harvoni contains two medicines that stop the hepatitis C virus from multiplying in your body. Ledipasvir blocks a protein called NS5A. Sofosbuvir blocks another protein called NS5B.

rosuvastatin

Rosuvastatin belongs to a class of drugs called statins. It works by blocking a substance your body needs to make cholesterol. This helps to lower your cholesterol levels.

Common Side Effects
ledipasvir/sofosbuvir
  • Feeling tired
  • Headache
  • Feeling weak
  • Nausea
rosuvastatin
  • Headache
  • Nausea
  • Muscle pain
  • Weakness
  • Constipation
FAERS Reports
ledipasvir/sofosbuvir
  • Feeling tired 4,130
  • Headache 3,706
  • Nausea 1,240
  • Diarrhea 913
  • Hepatitis C 883
rosuvastatin
  • Tiredness 11,698
  • Feeling sick to your stomach 10,037
  • Difficulty breathing 9,212
  • Loose stools 9,199
  • Muscle pain 8,784
Serious Warnings
ledipasvir/sofosbuvir

Harvoni can cause Hepatitis B to become active again if you have had it in the past. This can cause serious liver problems, including liver failure and death. Your doctor will test you for Hepatitis B before you start Harvoni and monitor you during and after treatment.

rosuvastatin

Rosuvastatin can cause muscle problems, including muscle pain, tenderness, or weakness. Tell your doctor right away if you have these symptoms, especially if you also have a fever or feel sick. Rosuvastatin can also cause liver problems. Your doctor may do blood tests to check your liver before and during treatment.

Pregnancy
ledipasvir/sofosbuvir

If you are pregnant or plan to become pregnant, talk to your doctor before taking Harvoni. If Harvoni is taken with ribavirin, it is unsafe during pregnancy. Talk to your doctor if you are breastfeeding or plan to breastfeed.

rosuvastatin

Do not take rosuvastatin if you are pregnant. It can harm your unborn baby. Talk to your doctor about other ways to control your cholesterol during pregnancy. Breastfeeding is not recommended while taking rosuvastatin.

Also Compare, Nearby Drugs

How to Read This ledipasvir/sofosbuvir vs rosuvastatin Comparison

ledipasvir/sofosbuvir is classified in the NS5A/NS5B Inhibitor (HCV) drug class, while rosuvastatin sits within the HMG-CoA Reductase Inhibitor (Statin) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, ledipasvir/sofosbuvir has 10,872 submissions while rosuvastatin has 48,930. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known moderate interaction flagged in FDA labeling, attributed to these medications can raise the levels of rosuvastatin in your blood to unsafe levels. this increases your risk of developing serious muscle problems.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between ledipasvir/sofosbuvir and rosuvastatin - always consult your physician or pharmacist first.

Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.